PTGX
Protagonist Therapeutics, Inc.NASDAQStock$98.91-2.30 (-2.27%)Mkt Cap 6.3BP/E —Div Yield —Beta 2.11Vol 229.7KAvg Vol 713.2K
52W$42.01
$105.98
ETFs That Hold PTGX (Protagonist Therapeutics, Inc.)
1M
-0.96%
3M
+24.06%
6M
+25.81%
YTD
+13.45%
1Y
+116.81%
3Y
+320.00%
5Y
+241.78%
ETFs That Hold PTGX
Protagonist Therapeutics, Inc. is held by 130 ETFs. The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
Excludes leveraged and inverse ETFs.
PreviousPage 7 of 7
Frequently Asked Questions
How many ETFs hold PTGX?
Protagonist Therapeutics, Inc. (PTGX) is held by 130 ETFs (excluding leveraged and inverse funds). The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
What is the largest ETF that holds PTGX?
By fund size, IJR (iShares Core S&P Small-Cap ETF) with $101.65B in AUM holds 0.36% of its portfolio in PTGX, representing $366.3M in market value.
What percentage of PBE is PTGX?
PTGX makes up 3.31% of PBE (Invesco Biotechnology & Genome ETF), making it one of the largest positions in that fund.
Is PTGX in the S&P 500?
PTGX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.